FindTrial
Sign In

Development of a Staging System and Survival Prediction Model for Advanced Gastric Cancer Patients without Adjuvant Treatment after Curative Gastrectomy

Survival Prediction Model for Advanced Gastric Cancer after Curative Gastrectomy without Adjuvant Treatment

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0006685
Enrollment
70
Registered
2021-10-25
Start date
2020-05-01
Completion date
Unknown
Last updated
2021-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, St. Vincent's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The inclusion criteria were: histologically confirmed primary gastric adenocarcinoma, curative R0 resection with D2 lymph node dissection, and pathologic stage II or III.

Exclusion criteria

Exclusion criteria: Exclusion criteria were: neoadjuvant or AC treatment, follow-up loss or death within 30 days of surgery, completion of total gastrectomy, and other malignancy within 5 years before gastrectomy.

Design outcomes

Primary

MeasureTime frame
Overall survival—

Countries

Korea, Republic of

Contacts

Public ContactKi Bum Park

The Catholic University of Korea, St. Vincent's Hospital

apzzap2@gmail.com+82-31-885-8966

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026